A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System

Enrolling by invitationOBSERVATIONAL
Enrollment

198

Participants

Timeline

Start Date

September 26, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2030

Conditions
Total Hip Arthroplasty (THA)OsteoarthritisDegenerative Joint DiseaseInflammatory ArthritisAvascular NecrosisPost-traumatic ArthritisCongenital Hip Dysplasia
Interventions
DEVICE

CATALYSTEM

CATALYSTEM Cementless Primary Hip System for participants with Total Hip Arthroplasty

Trial Locations (12)

10003

NYU Langone Health Orthopedic Hospital, New York

10021

Hospital for Special Surgery, New York

10032

Columbia University Medical Center, New York

27560

Duke Health, Morrisville

32806

Orlando Health Inc., Orlando

60016

Illinois Bone and Joint Institute, Des Plaines

94158

University of California at San Francisco, San Francisco

06518

Connecticut Orthopaedic Institute, Hamden

T6G 2B7

University of Alberta, Edmonton

V5Z 1M9

University of British Columbia, Vancouver

R2K 2M9

Concordia General Hospital, Winnipeg

N6A 5A5

London Health Sciences Centre (LHSC), London

All Listed Sponsors
lead

Smith & Nephew, Inc.

INDUSTRY